We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Breast Augmentation

This study is currently recruiting participants.
Verified September 2017 by University of North Carolina, Chapel Hill
Sponsor:
ClinicalTrials.gov Identifier:
NCT02008032
First Posted: December 11, 2013
Last Update Posted: September 14, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
University of North Carolina, Chapel Hill
  Purpose

Purpose:The aim of this research is to compare the 3D s-DBT (stationary digital breast tomosynthesis) and conventional 2-D digital mammography devices with regards to patient comfort and radiologist preference in women with breast implants.

Participants: Women with breast implants undergoing routine 2-D digital mammography.

Procedures (methods): 50 female subjects with breast implants undergoing conventional screening mammography will be recruited to have a single view s-DBT in the mediolateral projection. We will perform a patient preference study and radiologist reader study composed of radiologists who have experience evaluating tomosynthesis images. A short survey will be given to each patient about their preference in modality with respect to comfort. Each reader will review the images and score the ease of interpretation, and their confidence of interpretation.


Condition Intervention
Mammogram Scheduled Device: Stationary Breast Tomosynthesis

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Screening
Official Title: Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Breast Augmentation

Resource links provided by NLM:


Further study details as provided by University of North Carolina, Chapel Hill:

Primary Outcome Measures:
  • Receiver Operative Curve (ROC) Area Under the Curve (AUC) (percentage) [ Time Frame: 18 months ]
    Receiver Operative Curve (ROC) Area Under the Curve (AUC) analysis of the stationary breast tomosynthesis (SDBT) system for the the characterization of suspicious breast lesions in comparison to x-ray mammography.


Secondary Outcome Measures:
  • Reader preference - arbitrary units [ Time Frame: 18 months ]
    To evaluate radiologists confidence in evaluating specific lesion characteristics in suspicious breast lesions. Readers will be scored from -3 to +3.

  • Patient preference - arbitrary units [ Time Frame: 18 months ]
    To evaluate patient preference of screening methods. Preference will be scored from -3 to +3.


Estimated Enrollment: 50
Study Start Date: December 2013
Estimated Study Completion Date: May 2018
Estimated Primary Completion Date: May 2018 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: All patients
Stationary Breast Tomosynthesis
Device: Stationary Breast Tomosynthesis
The patient will have the SDBT study performed in a similar manner as conventional mammography in the mediolateral oblique and cranio-caudal plane. The participant will stand up and the mammography research technologist, ensuring patient comfort, will assist in positioning their breast in the breast tomosynthesis unit with standard compression. Once positioned, the total scan time is approximately 10 seconds. Both the left and right breast will be imaged. The length of time for the positioning and examination of a subject's breast may vary but it is expected that the entire imaging procedure will take about 5-10 min, including positioning time.

Detailed Description:

Patients will be recruited with assistance from a referring physician and through patients undergoing routine mammography in the breast imaging clinic.

All eligible women will be contacted by letter and/or phone call prior to scheduled mammography appointment to identify if they would be interested in participating in the research study. On the day of their conventional mammographic imaging, the study will be explained, and they will be offered the opportunity to participate. Consent will happen in a private room in the mammography clinic.

Once consent has been signed, a urine sample will be collected from women who can still become pregnant in order to complete a pregnancy test. Women who are pregnant are unable to participate in this study.

Women who consent for the study will be escorted by the research coordinator to a dressing room, where the subject will change into a gown. The research coordinator or research technologist will then escort the participant to the dedicated study room for the imaging exam. The patient will have the SDBT study performed in a similar manner as conventional mammography in the mediolateral oblique and cranio-caudal plane. The participant will stand up and the mammography research technologist, ensuring patient comfort, will assist in positioning their breast in the breast tomosynthesis unit with standard compression. Once positioned, the total scan time is approximately 10 seconds. Both the left and right breast will be imaged. The length of time for the positioning and examination of a subject's breast may vary but it is expected that the entire imaging procedure will take about 5-10 min, including positioning time.

The breast tomosynthesis scan will be acquired at a dose that is equal to or less than a diagnostic mammogram dose. Upon completion of the breast tomosynthesis exam, the research assistant will provide a short survey to be completed by the patient (less than 5 minutes). The survey will include questions such as the comfort level of s-DBT compared to the standard mammography.

The research SDBT exam will NOT be interpreted prior to the patient leaving the clinic. However, since there is theoretically a possibility of detecting an additional lesion not seen on conventional mammography, all images will be reviewed within a week by a qualified breast imaging specialist. If there are lesions of concern, these will be discussed with the referring surgeon or the patient's primary physician.

After completion of the patient acquisition, a reader study will be performed with five qualified radiologists.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Women at least 18 years old.
  • Able to provide informed consent.
  • History of breast augmentation mammoplasty (at least 1 year prior)

Exclusion Criteria:

  • Male. (It is uncommon for men to present for breast imaging)
  • Less than 18 years of age.
  • Patient unable to give consent. Institutionalized subject (prisoner or nursing home patient).
  • Any woman who is pregnant or has reason to believe she is pregnant or any woman who is lactating
  • Patient with a history of breast cancer (they would not be a screening exam)
  • Patient with a known breast cancer (they would not be a screening study)
  • Patient with a lump or nipple discharge (diagnostic population)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02008032


Contacts
Contact: Shanah R Kirk 919-966-6957 shanah_kirk@med.unc.edu
Contact: Doreen Steed 919-966-9284 doreen_steed@med.unc.edu

Locations
United States, North Carolina
UNC Hospital Recruiting
Chapel Hill, North Carolina, United States, 27599
Principal Investigator: Yueh Lee, MD, PhD         
Sub-Investigator: Donglin Zeng, PhD         
Sub-Investigator: Lynn Damitz, MD         
Sub-Investigator: Cherie Kuzmiak, DO         
Sponsors and Collaborators
University of North Carolina, Chapel Hill
Investigators
Principal Investigator: Yueh Lee, MD, PhD University of North Carolina, Chapel Hill
  More Information

Responsible Party: University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier: NCT02008032     History of Changes
Other Study ID Numbers: 13-1861
First Submitted: December 6, 2013
First Posted: December 11, 2013
Last Update Posted: September 14, 2017
Last Verified: September 2017

Keywords provided by University of North Carolina, Chapel Hill:
Mammography
Breast
Implants


To Top